FDA takes first step in possible reversal of ban on some peptides The Washington Post Regulatory Alert: The Legal Status of BPC 157 in Compounding and Clinical Practice Holt Law In 2023, the FDA deemed 19 peptides too unsafe to be dispensed by compounding pharmacies. Now, under RFK Jr., the agency is poised to reverse itself despite the fact that few The FDA has issued clear signals on BPC 157: it is not approved for human use in any form due to potential significant safety risks. This critical classification profoundly impacts research and Gray Market Peptides: So Much Hype, So Little Data BPC 157 What Athletes Need to Know About Legality, Safety and Efficacy Training & Conditioning